Securities code: 300110 securities abbreviation: Huaren Pharmaceutical Co.Ltd(300110) Announcement No.: 2021-071 Huaren Pharmaceutical Co.Ltd(300110)
Announcement of resolutions of the 10th (Interim) meeting of the 7th board of directors
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
The 10th meeting of the 7th board of directors of Huaren Pharmaceutical Co.Ltd(300110) (hereinafter referred to as “the company”) The (Interim) meeting was held at 9:30 on December 24, 2021 by combining on-site and Internet. The notice of the meeting was sent to all directors by e-mail on December 22, 2021. The meeting was convened and presided over by Mr. Yang Xiaodong, chairman of the board of directors. 9 directors should attend the meeting, 9 directors actually attended the meeting, and all supervisors and senior managers attended the meeting as nonvoting delegates. The meeting was held Comply with laws and regulations, the company law and the articles of association.
The meeting was presided over by Mr. Yang Xiaodong, chairman of the board of directors. After careful deliberation and voting, all directors attending the meeting formed the following resolutions:
1、 The proposal on by election of independent directors of the seventh board of directors was deliberated and adopted
After consideration, Xi’an Qujiang Tianshu health investment partnership, the controlling shareholder, is approved Mr. Liu Yong nominated by (limited partnership) is an independent director candidate of the seventh board of directors and submitted to the first extraordinary general meeting of shareholders in 2022 for deliberation. After being elected as an independent director by the general meeting of shareholders of the company, it is agreed that Mr. Liu Yong will serve as a member of the remuneration and assessment committee, nomination committee and Audit Committee of the seventh board of directors from the date of adoption of the general meeting of shareholders to the seventh session The term of office of the second board of directors expires.
Voting results: 9 in favor, 0 against and 0 abstention, which was adopted.
2、 The proposal on convening the first extraordinary general meeting of shareholders in 2022 was deliberated and adopted
The company will hold the first extraordinary general meeting of shareholders in 2022 at 14:00 on January 11, 2022 in the first conference room of the company. For details, see the notice on convening the first extraordinary general meeting in 2022 disclosed by the company on the information disclosure website designated by the China Securities Regulatory Commission on the gem on the same day.
Voting results: 9 in favor, 0 against and 0 abstention, which was adopted.
It is hereby announced.
Huaren Pharmaceutical Co.Ltd(300110) board of directors December 24, 2001
